Skip to content

Pattern of Statins Use in Catalonia

Pattern of Statins Use in Catalonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01477944
Enrollment
180723
Registered
2011-11-23
Start date
2012-02-29
Completion date
2012-02-29
Last updated
2012-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesteremia

Keywords

Statins pattern of use, Hypercholesterolemic patients, Statins

Brief summary

To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.

Detailed description

Pattern of statins use in Catalonia.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with a new prescription of statin Patients receiving one or more changes of the statins treatment

Exclusion criteria

* Patient with not full information

Design outcomes

Primary

MeasureTime frameDescription
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.From 1st September 2009 to 30th August 2010
Type of prescriberFrom 1st September 2009 to 30th August 2010Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.)
Date of change from previous statin to new.From 1st September 2009 to 30th August 2010

Secondary

MeasureTime frameDescription
High Density Lipoproteins (HDL) cholesterol concentrationFrom 1st September 2009 to 30th August 2010HDL data was collected till the last laboratory values before the date of change from previous statin to new statin.
Triglicerides (TG) concentrationFrom 1st September 2009 to 30th August 2010TG data was collected till the last laboratory values before the date of change from previous statin to new statin.
Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy.From 1st September 2009 to 30th August 2010
Serum Glucose concentrationFrom 1st September 2009 to 30th August 2010Serum Glucose data was collected till the last laboratory values before the date of change from previous statin to new statin.
Serum Creatin Kinase (CK) concentrationFrom 1st September 2009 to 30th August 2010CK data was collected till the last laboratory values before the date of change from previous statin to new statin.
Aspartate Aminotransferase (ASAT) concentrationFrom 1st September 2009 to 30th August 2010ASAT data was collected till the last laboratory values before the date of change from previous statin to new statin.
Total cholesterolFrom 1st September 2009 to 30th August 2010Total Cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin. That values will be collected for all the patients fulfilling criteria.
Low Density Lipoprotein (LDL) cholesterol concentrationFrom 1st September 2009 to 30th August 2010LDL cholesterol data was collected till the last laboratory values before the date of change from previous statin to new statin.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026